<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101491944</journal-id>
<journal-id journal-id-type="pubmed-jr-id">37344</journal-id>
<journal-id journal-id-type="nlm-ta">Atten Defic Hyperact Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">Atten Defic Hyperact Disord</journal-id>
<journal-title-group>
<journal-title>Attention deficit and hyperactivity disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">1866-6116</issn>
<issn pub-type="epub">1866-6647</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28176268</article-id>
<article-id pub-id-type="pmc">6233883</article-id>
<article-id pub-id-type="doi">10.1007/s12402-017-0219-8</article-id>
<article-id pub-id-type="manuscript">NIHMS940138</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>No genetic association between attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease in nine ADHD candidate SNPs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Geissler</surname>
<given-names>Julia M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1878-9647</contrib-id>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<collab>International Parkinson Disease Genomics Consortium members</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romanos</surname>
<given-names>Marcel</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerlach</surname>
<given-names>Manfred</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berg</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schulte</surname>
<given-names>Claudia</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Margarete-Höppel-Platz 1, 97080 Würzburg, Germany</aff>
<aff id="A2"><label>2</label>Department of Neurodegeneration, Hertie-Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany</aff>
<aff id="A3"><label>3</label>DZNE—German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany</aff>
<aff id="A4"><label>4</label>Department of Neurology, Christian-Albrechts-University, Kiel, Germany</aff>
<author-notes>
<corresp id="CR1">Julia M. Geissler, <email>Geissler_J@ukw.de</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P15"><bold>Conflict of interest</bold> On behalf of all authors, the corresponding author states that there is no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>13</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<fpage>121</fpage>
<lpage>127</lpage>
<!--elocation-id from pubmed: 10.1007/s12402-017-0219-8-->
<abstract id="ABS1">
<p id="P1">Attention-deficit/hyperactivity disorder (ADHD) and Parkinson’s disease (PD) involve pathological changes in brain structures such as the basal ganglia, which are essential for the control of motor and cognitive behavior and impulsivity. The cause of ADHD and PD remains unknown, but there is increasing evidence that both seem to result from a complicated interplay of genetic and environmental factors affecting numerous cellular processes and brain regions. To explore the possibility of common genetic pathways within the respective pathophysiologies, nine ADHD candidate single nucleotide polymorphisms (SNPs) in seven genes were tested for association with PD in 5333 cases and 12,019 healthy controls: one variant, respectively, in the genes coding for synaptosomal-associated protein 25 k (<italic>SNAP25</italic>), the dopamine (DA) transporter (<italic>SLC6A3</italic>; DAT1), DA receptor D4 (<italic>DRD4</italic>), serotonin receptor 1B (<italic>HTR1B</italic>), tryptophan hydroxylase 2 (<italic>TPH2</italic>), the norepinephrine transporter <italic>SLC6A2</italic> and three SNPs in cadherin 13 (<italic>CDH13</italic>). Information was extracted from a recent meta-analysis of five genome-wide association studies, in which 7,689,524 SNPs in European samples were successfully imputed. No significant association was observed after correction for multiple testing. Therefore, it is reasonable to conclude that candidate variants implicated in the pathogenesis of ADHD do not play a substantial role in PD.</p>
</abstract>
<kwd-group>
<kwd>ADHD</kwd>
<kwd>Parkinson’s disease</kwd>
<kwd>GWAS</kwd>
<kwd>SNPs</kwd>
<kwd>CDH13</kwd>
<kwd>Dopamine transporter</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>